Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Cash from Investing Activities (2016 - 2026)

Summit Therapeutics filings provide 13 years of Cash from Investing Activities readings, the most recent being -$238000.0 for Q1 2026.

  • Quarterly Cash from Investing Activities fell 100.15% to -$238000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$334.7 million through Mar 2026, down 414.05% year-over-year, with the annual reading at -$174.3 million for FY2025, 15.11% up from the prior year.
  • Cash from Investing Activities hit -$238000.0 in Q1 2026 for Summit Therapeutics, up from -$485.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $160.1 million in Q1 2025 and bottomed at -$645.1 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$57.0 million, with a median of -$71000.0 recorded in 2025.
  • Peak annual rise in Cash from Investing Activities hit 605580.0% in 2023, while the deepest fall reached 178587.81% in 2023.
  • Summit Therapeutics' Cash from Investing Activities stood at $10000.0 in 2022, then surged by 605580.0% to $60.6 million in 2023, then skyrocketed by 37.83% to $83.5 million in 2024, then tumbled by 681.15% to -$485.2 million in 2025, then soared by 99.95% to -$238000.0 in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Cash from Investing Activities are -$238000.0 (Q1 2026), -$485.2 million (Q4 2025), and -$71000.0 (Q3 2025).